nach oben

Erschienen in:

01.09.2017 | Original Article

The presence of anaemia negatively influences survival in patients with POLG disease

verfasst von: Omar Hikmat, Tzoulis Charalampos, Claus Klingenberg, Magnhild Rasmussen, Chantal M. E. Tallaksen, Eylert Brodtkorb, Torunn Fiskerstrand, Robert McFarland, Shamima Rahman, Laurence A. Bindoff

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Mitochondria play an important role in iron metabolism and haematopoietic cell homeostasis. Recent studies in mice showed that a mutation in the catalytic subunit of polymerase gamma (POLG) was associated with haematopoietic dysfunction including anaemia. The aim of this study was to analyse the frequency of anaemia in a large cohort of patients with POLG related disease.

Methods

We conducted a multi-national, retrospective study of 61 patients with confirmed, pathogenic biallelic POLG mutations from six centres, four in Norway and two in the United Kingdom. Clinical, laboratory and genetic data were collected using a structured questionnaire. Anaemia was defined as an abnormally low haemoglobin value adjusted for age and sex. Univariate survival analysis was performed using log-rank test to compare differences in survival time between categories.

Results

Anaemia occurred in 67% (41/61) of patients and in 23% (14/61) it was already present at clinical presentation. The frequency of anaemia in patients with early onset disease including Alpers syndrome and myocerebrohepatopathy spectrum (MCHS) was high (72%) and 35% (8/23) of these had anaemia at presentation. Survival analysis showed that the presence of anaemia was associated with a significantly worse survival (P = 0.004).

Conclusion

Our study reveals that anaemia can be a feature of POLG-related disease. Further, we show that its presence is associated with significantly worse prognosis either because anaemia itself is impacting survival or because it reflects the presence of more serious disease. In either case, our data suggests anaemia is a marker for negative prognosis.

Nur mit Berechtigung zugänglich

Ahlqvist KJ, Hamalainen RH, Yatsuga S et al (2012) Somatic progenitor cell vulnerability to mitochondrial DNA mutagenesis underlies progeroid phenotypes in Polg mutator mice. Cell Metab 15:100–109CrossRefPubMed

Ahlqvist KJ, Leoncini S, Pecorelli A et al (2015) MtDNA mutagenesis impairs elimination of mitochondria during erythroid maturation leading to enhanced erythrocyte destruction. Nat Commun 6:6494CrossRefPubMed

Antonicka H, Leary SC, Guercin GH et al (2003) Mutations in COX10 result in a defect in mitochondrial heme a biosynthesis and account for multiple, early-onset clinical phenotypes associated with isolated COX deficiency. Hum Mol Genet 12:2693–2702CrossRefPubMed

Burrage LC, Tang S, Wang J et al (2014) Mitochondrial myopathy, lactic acidosis, and sideroblastic anemia (MLASA) plus associated with a novel de novo mutation (m.8969G>a) in the mitochondrial encoded ATP6 gene. Mol Genet Metab 113:207–212CrossRefPubMedPubMedCentral

Camaschella C (2009) Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment. Semin Hematol 46:371–377CrossRefPubMed

Chen ML, Logan TD, Hochberg ML et al (2009) Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction. Blood 114:4045–4053CrossRefPubMedPubMedCentral

Clarke SL, Bowron A, Gonzalez IL et al (2013) Barth syndrome. Orphanet J Rare Dis 8:23CrossRefPubMedPubMedCentral

Fontenay M, Cathelin S, Amiot M, Gyan E, Solary E (2006) Mitochondria in hematopoiesis and hematological diseases. Oncogene 25:4757–4767CrossRefPubMed

Green DR, Kroemer G (2004) The pathophysiology of mitochondrial cell death. Science (N Y, NY) 305:626–629CrossRef

Hildick-Smith GJ, Cooney JD, Garone C et al (2013) Macrocytic anemia and mitochondriopathy resulting from a defect in sideroflexin 4. Am J Hum Genet 93:906–914CrossRefPubMedPubMedCentral

Hudson G, Chinnery PF (2006) Mitochondrial DNA polymerase-gamma and human disease. Hum Mol Genet 15 Spec No 2: R244-R252

Li-Harms X, Milasta S, Lynch J et al (2015) Mito-protective autophagy is impaired in erythroid cells of aged mtDNA-mutator mice. Blood 125:162–174CrossRefPubMedPubMedCentral

Lill R, Muhlenhoff U (2008) Maturation of iron-sulfur proteins in eukaryotes: mechanisms, connected processes, and diseases. Annu Rev Biochem 77:669–700CrossRefPubMed

Lu YW, Claypool SM (2015) Disorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genes. Front Genet 6:3CrossRefPubMedPubMedCentral

Morison IM, Cramer Borde EM, Cheesman EJ et al (2008) A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia. Nat Genet 40:387–389CrossRefPubMed

Nguyen KV, Sharief FS, Chan SS, Copeland WC, Naviaux RK (2006) Molecular diagnosis of Alpers syndrome. J Hepatol 45:108–116CrossRefPubMed

Nordin G, Martensson A, Swolin B et al (2004) A multicentre study of reference intervals for haemoglobin, basic blood cell counts and erythrocyte indices in the adult population of the Nordic countries. Scand J Clin Lab Invest 64:385–398CrossRefPubMed

Ojala T, Polinati P, Manninen T et al (2012) New mutation of mitochondrial DNAJC19 causing dilated and noncompaction cardiomyopathy, anemia, ataxia, and male genital anomalies. Pediatr Res 72:432–437CrossRefPubMed

Pearson HA, Lobel JS, Kocoshis SA et al (1979) A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr 95:976–984CrossRefPubMed

Rensvold JW, Krautkramer KA, Dowell JA, Denu JM, Pagliarini DJ (2016) Iron Deprivation Induces Transcriptional Regulation of Mitochondrial Biogenesis. J Biol Chem 291:20827-20837

Rensvold JW, Ong SE, Jeevananthan A, Carr SA, Mootha VK, Pagliarini DJ (2013) Complementary RNA and protein profiling identifies iron as a key regulator of mitochondrial biogenesis. Cell Rep 3:237–245CrossRefPubMed

Richardson DR, Lane DJ, Becker EM et al (2010) Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc Natl Acad Sci U S A 107:10775–10782CrossRefPubMedPubMedCentral

Riley LG, Rudinger-Thirion J, Schmitz-Abe K et al (2016) LARS2 variants associated with hydrops, lactic acidosis, sideroblastic anemia, and multisystem failure. JIMD Rep 28:49–57CrossRefPubMed

Rotig A, Bourgeron T, Chretien D, Rustin P, Munnich A (1995) Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Hum Mol Genet 4:1327–1330CrossRefPubMed

Saneto RP, Naviaux RK (2010) Polymerase gamma disease through the ages. Dev Disabil Res Rev 16:163–174CrossRefPubMed

Schmitz-Abe K, Ciesielski SJ, Schmidt PJ et al (2015) Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9. Blood 126:2734–2738CrossRefPubMedPubMedCentral

Shteyer E, Saada A, Shaag A et al (2009) Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene. Am J Hum Genet 84:412–417CrossRefPubMedPubMedCentral

Torraco A, Bianchi M, Verrigni D et al (2017) A novel mutation in NDUFB11 unveils a new clinical phenotype associated with lactic acidosis and sideroblastic anemia. Clin Genet 91:441–447CrossRefPubMed

Trifunovic A, Wredenberg A, Falkenberg M et al (2004) Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429:417–423CrossRefPubMed

Tzoulis C, Engelsen BA, Telstad W et al (2006) The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 129:1685–1692CrossRefPubMed

Wedatilake Y, Niazi R, Fassone E et al (2016) TRNT1 deficiency: clinical, biochemical and molecular genetic features. Orphanet J Rare Dis 11:90CrossRefPubMedPubMedCentral

Winterthun S, Ferrari G, He L et al (2005) Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations. Neurology 64:1204–1208CrossRefPubMed

Wortmann SB, Zietkiewicz S, Kousi M et al (2015) CLPB mutations cause 3-methylglutaconic aciduria, progressive brain atrophy, intellectual disability, congenital neutropenia, cataracts, movement disorder. Am J Hum Genet 96:245–257CrossRefPubMedPubMedCentral

Titel: The presence of anaemia negatively influences survival in patients with POLG disease
verfasst von: Omar Hikmat
Tzoulis Charalampos
Claus Klingenberg
Magnhild Rasmussen
Chantal M. E. Tallaksen
Eylert Brodtkorb
Torunn Fiskerstrand
Robert McFarland
Shamima Rahman
Laurence A. Bindoff
Publikationsdatum: 01.09.2017
Verlag: Springer Netherlands
Erschienen in: Journal of Inherited Metabolic Disease / Ausgabe 6/2017
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI: https://doi.org/10.1007/s10545-017-0084-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The presence of anaemia negatively influences survival in patients with POLG disease

Abstract

Background

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2017

Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial

Liver involvement in urea cycle disorders: a review of the literature

Vitamin B6 is essential for serine de novo biosynthesis

News and views

K. Sarafoglou, G. F. Hoffmann, K. S. Roth (eds): Pediatric endocrinology and inborn errors of metabolism. Second edition

PRKAG2 mutations presenting in infancy

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin